RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tenax Therapeutics Stock

Tenax Therapeutics P/E 2024

Tenax Therapeutics P/E

-0.04

Ticker

TENX

ISIN

US88032L2097

WKN

A2JEYS

As of Sep 29, 2024, Tenax Therapeutics's P/E ratio was -0.04, a -95.7% change from the -0.93 P/E ratio recorded in the previous year.

The Tenax Therapeutics P/E history

Tenax Therapeutics Aktienanalyse

What does Tenax Therapeutics do?

Tenax Therapeutics Inc. is a biopharmaceutical company based in Morrisville, North Carolina. It specializes in the development of therapeutics for cardiovascular and pulmonary diseases. The company was founded in 1967 by a group of physicians and scientists. Formerly known as Oxygen Biotherapeutics, it was rebranded as Tenax Therapeutics in 2014. Tenax Therapeutics' business model is focused on the development, manufacturing, and marketing of products for rare diseases. The company aims to develop innovative therapies for severe and life-threatening diseases where there is a high demand for novel treatment options. The focus of Tenax Therapeutics is on cardiovascular and respiratory diseases. The company specializes in the development of medications for the treatment of severe or life-threatening conditions such as cardiogenic shock, pulmonary hypertension, and pulmonary embolism. Over the years, Tenax Therapeutics has established several divisions to streamline its research and development activities. One of the key divisions is clinical research, where the company conducts clinical trials to test the efficacy and safety of its products and obtain regulatory approval. Another pillar of the company is product development, where Tenax Therapeutics develops new compounds and medications to specifically target conditions like cardiogenic shock. Given the high demand for new therapies for rare diseases, the company adopts a highly focused approach and concentrates on developing products for specific indications. Tenax Therapeutics' extensive product portfolio includes various medications and therapeutics that can be used to treat cardiovascular and pulmonary diseases. One important representative in this area is Levosimendan, a vasodilator and inotropic medication used in patients with cardiogenic shock, as well as heart failure and other cardiovascular conditions. Another product in Tenax Therapeutics' portfolio is the active substance ANX-188. This medication is used for the treatment of patients with severe cardiogenic shock and has already been tested in clinical trials. Overall, Tenax Therapeutics aims to develop innovative and effective therapies for rare diseases of the cardiovascular and pulmonary systems. The company strives to address the medical need in this field and ensure high patient satisfaction. Tenax Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Tenax Therapeutics's P/E Ratio

The Price to Earnings (P/E) Ratio of Tenax Therapeutics is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Tenax Therapeutics's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Tenax Therapeutics is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Tenax Therapeutics’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Tenax Therapeutics stock

What is the price-to-earnings ratio of Tenax Therapeutics?

The price-earnings ratio of Tenax Therapeutics is currently -0.04.

How has the price-earnings ratio of Tenax Therapeutics changed compared to last year?

The price-to-earnings ratio of Tenax Therapeutics has increased by -95.7% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Tenax Therapeutics high compared to other companies?

Yes, the price-to-earnings ratio of Tenax Therapeutics is high compared to other companies.

How does an increase in the price-earnings ratio of Tenax Therapeutics affect the company?

An increase in the price-earnings ratio of Tenax Therapeutics would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Tenax Therapeutics affect the company?

A decrease in the price-earnings ratio of Tenax Therapeutics would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Tenax Therapeutics?

Some factors that influence the price-earnings ratio of Tenax Therapeutics are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Tenax Therapeutics pay?

Over the past 12 months, Tenax Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tenax Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Tenax Therapeutics?

The current dividend yield of Tenax Therapeutics is .

When does Tenax Therapeutics pay dividends?

Tenax Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tenax Therapeutics?

Tenax Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Tenax Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tenax Therapeutics located?

Tenax Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tenax Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tenax Therapeutics from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Tenax Therapeutics pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Tenax Therapeutics in the year 2023?

In the year 2023, Tenax Therapeutics distributed 0 USD as dividends.

In which currency does Tenax Therapeutics pay out the dividend?

The dividends of Tenax Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Tenax Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Tenax Therapeutics

Our stock analysis for Tenax Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tenax Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.